{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:45:23Z","timestamp":1785894323396,"version":"3.56.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100019844","name":"AlphaTau Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007052","name":"Memorial Sloan Kettering Cancer Center","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100007052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015593","name":"American Austrian Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030732","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.brachy.2026.03.012","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T11:14:56Z","timestamp":1778930096000},"page":"648-657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early outcomes of partial gland (focal) salvage brachytherapy for radiorecurrent prostate cancer"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7625-5427","authenticated-orcid":false,"given":"Aneesh","family":"Dhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0462-188X","authenticated-orcid":false,"given":"Sankalp","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0529-0812","authenticated-orcid":false,"given":"Daniel","family":"Gorovets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assaf","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2381-6910","authenticated-orcid":false,"given":"Himanshu","family":"Nagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio L","family":"Damato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8973-5139","authenticated-orcid":false,"given":"Joel","family":"Beaudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4342-7066","authenticated-orcid":false,"given":"Marisa A","family":"Kollmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2026.03.012_bib0001","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2403365","article-title":"Phase 3 trial of stereotactic body radiotherapy in localized prostate cancer","volume":"391","author":"van As","year":"2024","journal-title":"New Engl J Med"},{"key":"10.1016\/j.brachy.2026.03.012_bib0002","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.brachy.2011.08.003","article-title":"Predicting biochemical tumor control after brachytherapy for clinically localized prostate cancer: The Memorial Sloan-Kettering Cancer Center experience","volume":"11","author":"Zelefsky","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2026.03.012_bib0003","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brachy.2014.06.008","article-title":"Permanent prostate brachytherapy with or without supplemental external beam radiotherapy as practiced in Japan: Outcomes of 1300 patients","volume":"14","author":"Yorozu","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2026.03.012_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110381","article-title":"Prostate high dose-rate brachytherapy as monotherapy for low and intermediate-risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy: A 9-year update","volume":"198","author":"Hudson","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2026.03.012_bib0005","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41391-023-00712-z","article-title":"Biochemical recurrence in patients with prostate cancer after primary definitive therapy: Treatment based on risk stratification","volume":"27","author":"Shore","year":"2024","journal-title":"Prostat Cancer Prostat Dis"},{"key":"10.1016\/j.brachy.2026.03.012_bib0006","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.eururo.2022.07.011","article-title":"Local failure events in prostate cancer treated with radiotherapy: A pooled analysis of 18 randomized trials from the meta-analysis of randomized trials in cancer of the prostate consortium (LEVIATHAN)","volume":"82","author":"Ma","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.brachy.2026.03.012_bib0007","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ijrobp.2021.10.138","article-title":"Salvage low-dose-rate prostate brachytherapy: Clinical outcomes of a phase 2 trial for local recurrence after external beam radiation therapy (NRG oncology\/RTOG 0526)","volume":"112","author":"Crook","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2026.03.012_bib0008","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijrobp.2018.09.039","article-title":"A prospective phase 2 trial of transperineal ultrasound-guided brachytherapy for locally recurrent prostate cancer after external beam radiation therapy (NRG oncology\/RTOG-0526)","volume":"103","author":"Crook","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2026.03.012_bib0009","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.brachy.2017.07.013","article-title":"Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: A comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time","volume":"16","author":"Kollmeier","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2026.03.012_bib0010","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.eururo.2020.11.010","article-title":"A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER)","volume":"80","author":"Valle","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.brachy.2026.03.012_bib0011","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.euo.2020.01.002","article-title":"Detection of recurrent prostate cancer using prostate-specific membrane antigen positron emission tomography in patients not meeting the Phoenix criteria for biochemical recurrence after curative radiotherapy","volume":"4","author":"Jansen","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.brachy.2026.03.012_bib0012","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ijrobp.2019.11.001","article-title":"A prospective study of 18F-DCFPyL PSMA PET\/CT restaging in recurrent prostate cancer following primary external beam radiotherapy or brachytherapy","volume":"106","author":"Liu","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2026.03.012_bib0013","first-page":"41","article-title":"Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET\/CT and multi-parametric MRI","volume":"32","author":"Liu","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.brachy.2026.03.012_bib0014","article-title":"MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer","volume":"12","author":"M\u00e9nard","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.brachy.2026.03.012_bib0015","doi-asserted-by":"crossref","first-page":"e531","DOI":"10.1016\/j.prro.2022.05.018","article-title":"A prospective study of magnetic resonance imaging-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: Updated results of 30 patients","volume":"12","author":"Corkum","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2026.03.012_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109495","article-title":"Recurrence characteristics after focal salvage HDR brachytherapy in prostate cancer","volume":"180","author":"Rasing","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2026.03.012_bib0017","article-title":"Salvage low-dose-rate brachytherapy for locally recurrent prostate cancer after definitive irradiation","volume":"48","author":"Meraouna","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.brachy.2026.03.012_bib0018","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.brachy.2006.03.004","article-title":"Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer","volume":"5","author":"Yamada","year":"2006","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2026.03.012_bib0019","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0360-3016(00)00655-6","article-title":"Postimplantation dosimetric analysis of permanent transperineal prostate implantation: Improved dose distributions with an intraoperative computer-optimized conformal planning technique","volume":"48","author":"Zelefsky","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2026.03.012_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.prro.2025.03.009","article-title":"Implantable rectal spacers in prostate cancer radiation therapy: A systematic review","author":"Lippens","year":"2025","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2026.03.012_bib0021","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.urology.2023.12.034","article-title":"Major complications and adverse events related to use of SpaceOAR hydrogel for prostate cancer radiotherapy","volume":"188","author":"Millot","year":"2024","journal-title":"Urology"},{"key":"10.1016\/j.brachy.2026.03.012_bib0022","first-page":"uaaf013","article-title":"Rectal complications following SpaceOAR insertion after prior pelvic radiation","volume":"11","author":"Yates","year":"2025","journal-title":"BJR Case Rep"},{"key":"10.1016\/j.brachy.2026.03.012_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109672","article-title":"Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study","volume":"184","author":"Corkum","year":"2023","journal-title":"Radiother Oncol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472126000401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472126000401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:48:32Z","timestamp":1785890912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472126000401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1538472126000401"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2026.03.012","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early outcomes of partial gland (focal) salvage brachytherapy for radiorecurrent prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2026.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}